EUVIMED · CrossrefZeitschrift
Oncology Research
ISSN 1555-3906 · Tech Science Press
Neueste Artikel
Male Breast Cancer: Epidemiology, Diagnosis, Molecular Mechanisms, Therapeutics, and Future Prospective
Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics
PIK3R1 as a Gastric Cancer Biomarker Linked to CD73+ Treg-Mediated Immunosuppression
ETV4-Mediated PD-L1 Upregulation Promotes Immune Evasion and Predicts Poor Immunotherapy Response in Melanoma
AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism
Branched-Chain Amino Acid Metabolic Reprogramming and Cancer: Molecular Mechanisms, Immune Regulation, and Precision Targeting
A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy
Ferroptosis as a Translational Axis in Small Cell Lung Cancer: A Systematic Review of Redox Pathways and Precision Oncology Prospects
Novel Small Molecule DZ-865B Effectively Degrades BCL6, Promotes Apoptosis and Reduces Proliferation of Diffuse Large B-Cell Lymphoma Cells
Regulation of Histone Emulsification by HPDL via LDHA/LDHB Promotes EC Cell Proliferation
Advances in Systemic Therapy for Unresectable Hepatocellular Carcinoma: Commentary on The Impact of the STRIDE Regimen in HIMALAYA Trial
TDO2-Associated Tryptophan Metabolism Correlates with Impaired Tertiary Lymphoid Structure Maturation and Reduced B Cell Class Switching in Breast Cancer
Lactic Acid Drives ESM1 to Attenuate DNA Damage and CD8+ T Cell Infiltration in Cancer
Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation
Comparative Analysis of Tumor Microbiota Identifies a Metastatic-Specific Bacterial Signature, Highlighting Streptococcus spp. As the Predominant Hub across Cancers
In Vivo CAR-T Therapy for Cancer Treatment: Mechanisms, Technological Advances, and Clinical Translation
Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data
Germinal Center–Like Tertiary Lymphoid Structures Mark Immune Responsiveness and Enable Checkpoint Immunotherapy in Bladder Cancer
Engineering the Future of ADCs in Non-Small Cell Lung Cancer
Prognostic Value of Spatial and Topological Features of Tumor Microenvironment in Classic Hodgkin Lymphoma
PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway
Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications
Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report
Altered Expression of UFMylation Pathway Proteins Is Linked with Cancer Stem Cell Features and Aggressive Clinical Phenotype of Head and Neck Cancer
ESM1 Enhances H3K9 Lactylation-Mediated GPRC5A Transcription to Induce mTOR Pathway Activation and Cisplatin Resistance in Ovarian Cancer
Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies
Natural Products as Modulators of circRNAs: Current Mechanistic Insights and Therapeutic Prospects in Cancer
Circulating Tumor Cells and Cell-Free DNA during Three or Six Months of Adjuvant Chemotherapy in Stage III Colorectal Cancer
Investigating the Oncogenic Roles of Carboxypeptidase Q (CPQ) in Glioblastoma: Insights from RNA-Sequencing Data and Experimental Validation
Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation
EUVIMED